Syneos Health Cash and Cash Equivalents 2011-2026 | SYNH

Annual Cash and Cash Equivalents Syneos Health

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
106 M	272 M	164 M	156 M	321 M	102 M	85 M	126 M	97 M	81.4 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
321 M	81.4 M	151 M

Quarterly Cash and Cash Equivalents Syneos Health

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
111 M	112 M	-	-	119 M	106 M	123 M	261 M	265 M	272 M	272 M	272 M	272 M	164 M	164 M	164 M	164 M	154 M	132 M	172 M	187 M	321 M	321 M	321 M	321 M	102 M	102 M	102 M	102 M	85 M	85 M	85 M	85 M	126 M	126 M	126 M	126 M	97 M	-	-	-	81.4 M	-	-	-	71 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
321 M	71 M	165 M

Cash and Cash Equivalents of other stocks in the Diagnostics research industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	19.1 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	59.4 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	13.3 M	-	-6.19 %	$ 10.5 M	USA
Bioventus BVS	51.2 M	$ 9.0	1.47 %	$ 600 M	USA
Brainsway Ltd. BWAY	69.3 M	$ 13.99	2.49 %	$ 99.4 M	Israel
Castle Biosciences CSTL	120 M	$ 26.24	1.59 %	$ 729 M	USA
Charles River Laboratories International CRL	214 M	$ 154.17	1.45 %	$ 7.64 B	USA
DexCom DXCM	918 M	$ 68.54	3.32 %	$ 26.7 B	USA
CareDx, Inc CDNA	65.4 M	$ 17.77	2.6 %	$ 947 M	USA
Guardant Health GH	378 M	$ 88.16	1.12 %	$ 11.1 B	USA
Accelerate Diagnostics AXDX	34.9 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	956 M	$ 103.95	0.1 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	6.66 B	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11.7 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	176 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	55.1 M	$ 15.57	4.15 %	$ 471 M	USA
Biodesix BDSX	26.2 M	$ 17.22	-0.4 %	$ 2.23 B	USA
ICON Public Limited Company ICLR	752 M	$ 101.08	3.55 %	$ 8.34 B	Irlanda
Anixa Biosciences ANIX	1.24 M	$ 2.88	1.23 %	$ 93.5 K	USA
IQVIA Holdings IQV	1.98 B	$ 169.85	3.01 %	$ 29.2 B	USA
Danaher Corporation DHR	4.62 B	$ 195.65	2.23 %	$ 139 B	USA
Biocept BIOC	12.9 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	157 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	12.2 M	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	1.13 B	$ 121.72	2.04 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	420 M	$ 198.39	-0.28 %	$ 22 B	USA
QIAGEN N.V. QGEN	598 M	-	-	$ 10.6 B	Niderland
Agilent Technologies A	1.48 B	$ 113.9	1.85 %	$ 34.6 B	USA
BioNano Genomics BNGO	9.17 M	$ 1.12	0.91 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	36.8 M	$ 9.28	10.24 %	$ 263 M	Israel
NeoGenomics NEO	160 M	$ 8.39	1.76 %	$ 1.07 B	USA
Neogen Corporation NEOG	129 M	$ 9.45	3.73 %	$ 2.05 B	USA
Lantheus Holdings LNTH	359 M	$ 78.83	0.41 %	$ 5.32 B	USA
Chembio Diagnostics CEMI	18.2 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	7.7 M	-	-	$ 9.42 M	Israel
Pacific Biosciences of California PACB	63.7 M	$ 1.41	3.68 %	$ 423 M	USA
Co-Diagnostics CODX	14.9 M	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	497 M	$ 458.61	1.1 %	$ 13.2 B	USA
Motus GI Holdings MOTS	4.96 M	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.9 M	$ 1 220.43	1.77 %	$ 25.2 B	Schweiz
Celcuity CELC	22.5 M	$ 115.07	0.15 %	$ 4.54 B	USA
DermTech DMTK	36.7 M	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	4.14 M	$ 18.31	5.23 %	$ 410 M	USA
Invitae Corporation NVTA	257 M	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	52.4 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	466 M	$ 201.15	1.76 %	$ 19.8 B	USA
OPKO Health OPK	427 M	$ 1.2	0.84 %	$ 833 M	USA